During the last month, Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) has reported several significant developments and is an opportunity that we are closely following. From forming strategic partnerships to purchasing cannabis biomass to launch a line of cannabis 2.0 products, Pure Extracts has been executing on…
-Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, today announced key senior management changes to lead the buildout of its development and clinical operations in the United States and Europe. Effective immediately, Alexander Belser, PhD, will serve as Chief Clinical Officer, and Aaron Bartlone will serve as…
Over the past year there has been a significant increase in interest in companies that are focused on the psychedelic therapy market--a trend that we are following closely. Interest in these companies has been steadily rising in 2021, and we are focused on identifying businesses that have staying power. Tryp…
If you have not been following Field Trip Health Ltd. (CSE: FTRP) (OTCQX: FTRPF), you may want to put the company on your radar after it closed a massive private placement. Last week, Field Trip reported to have closed a previously announced $95 million bought deal short form prospectus offering.…
Rritual Superfoods Inc. (CSE: RSF) (CSE: RSF.WT) is pleased to provide an update on its upcoming US retail launch of its plant-based superfood elixirs. Rritual has successfully completed a second commercial scale manufacturing run which is approximately 50% larger than its initial production run. Production for early April is scheduled and…
The psychedelic therapy market is one of the most exciting emerging industries and is a vertical that we have been highly focused on. We expect 2021 to be a transformational year for the psychedelic sector as companies prepare to report Phase 3 clinical trial data. We expect positive phase 3…
Rritual Superfoods Inc. ("Rritual" or the "Company") (CSE: RSF) (CSE: RSF.WT) is pleased to provide shareholders with a corporate update outlining the successful launch and implementation of the company's US facing E-commerce website as well as highlight other key corporate milestones such as the ECRM Buyers Choice Award and receiving USDA Organic Certification. Launch…
Tryp Therapeutics Inc. (CSE: TRYP) ("Tryp" or the "Company"), a pharmaceutical company focused on identifying and developing clinical-stage compounds for diseases with high unmet medical needs, is pleased to announce that it has appointed Luke Hayes as its Chief Financial Officer. Mr. Hayes has been active in the life science…
Rritual Superfoods Inc. (CSE: RSF; RSF.WT) announced that it has closed its previously announced initial public offering and raised total gross proceeds of $6,000,000. On February 26, 2021, the Company obtained a receipt for its final prospectus filed with the securities regulatory authorities in each of the provinces of Canada…
The psychedelic therapy market is one of the most exciting emerging industries and is a vertical that we are bullish on. The COVID pandemic has put a major emphasis on the value of mental health and we expect the psychedelic therapy industry to gain from this recognition. During the last…
